AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Barrier to Sustainable Pharmaceuticals
pharma wants to mandate with symptomology by giving products that don't do that because then the money trade or the money trade is gone, right? Because now these people can take these drugs which then create a calvocade of side effects and other things that happen. Whereas peptides and bio regulators are actually literally, as he can tell you, will cure the issue altogether if used correctly and surgically precise dosages. I mean, so a good example of that is look at the Hep C treatment. It goes by multiple names, but essentially Hep C cure. In the US and Europe, they charge anywhere from $50,000 to $30,000 for it. In India,